Lupin Limited (NSE:LUPIN)
India · Delayed Price · Currency is INR 2,165.70
-22.70 (-1.04%)
Sep 1, 2026, 10:10 AM IST
Lupin Market Cap
Lupin has a market cap or net worth of 995.86 billion as of August 31, 2026. Its market cap has increased by 15.17% in one year.
Market Cap
995.86B
Enterprise Value
983.72B
Revenue
299.67B
Ranking
n/a
PE Ratio
18.01
Stock Price
2,165.70
ChartMarket Cap Chart
Since September 29, 1999, Lupin's market cap has increased from 998.14M to 995.86B, an increase of 99,671.51%. That is a compound annual growth rate of 29.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 995.86B | 3.22% |
| Dec 31, 2025 | 964.76B | -10.05% |
| Dec 31, 2024 | 1.07T | 78.05% |
| Dec 29, 2023 | 602.42B | 80.75% |
| Dec 30, 2022 | 333.29B | -22.86% |
| Dec 31, 2021 | 432.05B | -2.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.45T |
| Zydus Lifesciences | 1.19T |
| Cipla | 1.15T |
| Laurus Labs | 1.05T |
| Mankind Pharma | 984.13B |
| Aurobindo Pharma | 946.67B |
| Glenmark Pharmaceuticals | 709.74B |
| Alkem Laboratories | 640.27B |